Status:
COMPLETED
Retrospective Review on Patients With Recurrent Asthmatic Attacks Requiring Hospitalizations
Lead Sponsor:
Chinese University of Hong Kong
Collaborating Sponsors:
United Christian Hospital
Princess Margaret Hospital, Hong Kong
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Brief Summary
Asthma is a common respiratory disease. around the world. Asthma exacerbation is one of the major sequelae and associated with various morbidity and mortality. A satisfactory asthma control can help t...
Detailed Description
Asthma is a common respiratory disease worldwide and in Hong Kong. According to the estimation by the Center for Disease Control and Prevention in 2015, 7.6% adults in the United States have asthma. I...
Eligibility Criteria
Inclusion
- All patients with hospitalization for asthmatic exacerbation according to physician's clinical judgement
- Age greater than 18 years old
Exclusion
- \- Inappropriate diagnosis of asthma exacerbation after evaluation
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
2280 Patients enrolled
Trial Details
Trial ID
NCT04479501
Start Date
December 1 2017
End Date
December 31 2019
Last Update
July 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese University of Hong Kong
Hong Kong, Hong Kong